Skip to main content
[Preprint]. 2023 Feb 16:2023.02.15.23286003. [Version 1] doi: 10.1101/2023.02.15.23286003

Table 1:

Study Population Demographics with characteristics Non-Prescriber’s-Choice Adherent vs Prescriber’s-Choice Adherence Cohorts

Variables Overall
n= 265,409
Non-Prescribers’-Choice Adherent
n=106,899
Prescribers’- Choice Adherent
n=158,510
Age, Mean (std), y 70.6 (14.7) 70.7 (15.3) 70.6 (14.3)
Sex, female 50.3% 50.0% 50.4%
Race/Ethnicity
White 68.6% 66.3% 70.1%
African American (AA) 17.6% 20.7% 15.5%
Hispanic 13.8% 13.0% 14.36%
Stroke Type: Acute Ischemic Stroke 73.7% 73.6% 73.8%
Transient Ischemic Attack 10.9% 10.8% 11%
Subarachnoid Hemorrhage 3.9% 3.9% 3.9%
Intracerebral hemorrhage 11.3% 11.6% 11.1%
Acute Ischemic Stroke Etiology (TOAST Criteria)
Cardio embolism 7.5% 8.2% 7.0%
Cryptogenic 8.8% 8.8% 8.8%
Large Vessel Atherosclerosis 5.7% 5.9% 6.9%
Small vessel occlusion 6.4% 5.6% 6.9%
Stroke of Other determined 1.0% 1.1% 1%
Unknown 70.5% 70.4% 70.6%
Insurance, %
Private 38.2% 37.5% 38.6%
Medicare 44.2% 45% 43.5%
Medicaid 5.0% 5.1% 5.0%
Self-pay 10.4% 10.0% 10.9%
Diabetes 31.8% 37.6% 27.8%
Atrial Fibrillation/Flutter 18.3% 23.5% 14.9%
Prior Stroke or TIA 29.4% 30.1% 28.9%
Discharged Home 48.4% 44.2% 51.3%
Modified Rankin Scale at discharge
mRS 0-2 43.4% 39.7% 45.8%
mRS 3-5 51.3% 50.9% 51.5%
mRS 6 5.4% 9.3% 2.7%